Cencora (COR) Stock: Buy, Sell, or Hold?
COR - Cencora, Inc.
$321.57
0.62 (0.19%)
â˛
5d:
-4.64%
30d:
+2.36%
90d:
+14.24%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When COR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: COR is fairly priced but lacks strong directional signals. At -0.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: COR is fairly priced but lacks strong directional signals. At -0.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$464.69
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$288.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: COR is currently trading at $321.57, which is considered fair relative to its 30-day fair value range of $312.79 to $329.49. The stock's valuation (Forward PE: 16.3) is in line with its historical norms (16.5). Remarkably, the market is currently pricing in an annual earnings decline of 0.5% over the next few years. This pessimistic expectation contrasts with the company's recent 11.9% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, COR is in a strong uptrend. The price is currently testing key support at $317.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: COR scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $369.31 (+14.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, COR is in a strong uptrend. The price is currently testing key support at $317.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: COR scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $369.31 (+14.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$312.79 -
$329.49
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.6%
Protect Your Profits
Holding COR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($369.31)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$312.79 -
$329.49
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$317.96
Resistance Level
$338.71
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.26
Wall Street Target
$369.31
(+14.8%)
Revenue Growth (YoY)
5.1%
Earnings Growth (YoY)
11.9%
Profit Margin
0.8%
Valuation Discount vs History
-0.5% cheaper
PE vs Historical
16.3 vs 16.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.5%
(market-implied from PE analysis)
1-Year Target
$319.96
(-1%)
2-Year Target
$318.36
(-1%)
3-Year Target
$316.77
(-2%)
3-Yr Target (if PE normalizes)
(PE: 16â17)
$321.48
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 10.7%)
$540.61
(+68%)
Base:
(SPY PE: 16.3, Growth: 10.7%)
$435.77
(+36%)
Bear:
(PE: 13.8, Growth: 10.7%)
$370.40
(+15%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (16x PE) as earnings recover.
Trailing PE: 23.99 | Current EPS (TTM): $13.38
Bull Case
$521.88
(+62%)
Analyst growth 47.8%, PE expands to 26.4
Base Case
$474.44
(+48%)
Market implied 47.8%, PE stable at 24.0
Bear Case
$218.25
(-32%)
Severe decline -20.0%, PE contracts to 20.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.3 to 16.5
Stabilization Target:
$326.35
(+1.5%)
PE Expansion Potential:
+1.5%
Share & Embed Analysis
Last updated: September 12, 2026 9:37 AM ET
Data refreshes hourly during market hours. Next update: 10:37 AM
Data refreshes hourly during market hours. Next update: 10:37 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$987 | 51 HOLD |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$271 | 55 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$98 | 46 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 46 HOLD |
Advanced COR Option Strategies
Professional options setups generated by AI based on today's COR price and gamma walls.
